SHP.L - Shire plc

LSE - LSE Delayed Price. Currency in GBp
4,358.00
+57.50 (+1.34%)
At close: 4:39PM BST
Stock chart is not supported by your current browser
Previous Close4,300.50
Open4,300.50
Bid4,220.00 x 51000
Ask4,380.00 x 53800
Day's Range4,300.50 - 4,372.00
52 Week Range2,940.50 - 4,662.00
Volume1,745,066
Avg. Volume2,500,287
Market Cap39.553B
Beta (3Y Monthly)1.19
PE Ratio (TTM)8.26
EPS (TTM)527.50
Earnings DateOct 25, 2018
Forward Dividend & Yield0.26 (0.60%)
Ex-Dividend Date2018-09-06
1y Target Est63.49
  • Reuters9 hours ago

    FTSE shrugs off Brexit impasse while Convatec and Superdry sink

    By Danilo Masoni and Helen Reid MILAN/LONDON (Reuters) - Britain's top share index managed a modest gain on Monday as a deadlock in Brexit talks depressed domestic stocks but helped multinational exporter ...

  • GlobeNewswire19 hours ago

    Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR.

  • Irish bioscience company opens new $1.2 billion Georgia plant
    American City Business Journals4 days ago

    Irish bioscience company opens new $1.2 billion Georgia plant

    Shire already employs about 900 people. But when it fully ramps up in Georgia, it’s expected to have about 1,500 workers between the manufacturing facility and its plasma collection centers.

  • GlobeNewswire4 days ago

    Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR.

  • GlobeNewswire5 days ago

    Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR.

  • J&J's Stelara Succeeds in Phase III Ulcerative Colitis Study
    Zacks5 days ago

    J&J's Stelara Succeeds in Phase III Ulcerative Colitis Study

    J&J's (JNJ) Stelara induces clinical remission and response in ulcerative colitis patients who had failed prior therapy, per data from a phase III study.

  • GlobeNewswire6 days ago

    Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR.

  • Moody's6 days ago

    Seven & i Holdings Co., Ltd. -- Moody's: Rated Japanese corporates' cash to stay high, but pace of growth to slow

    Moody's Japan K.K. says that the cash levels of rated Japanese non-financial companies will remain high through at least fiscal 2018 -- ending 31 March 2019 for most companies -- but that the pace of growth will slow as spending increases. "One indication of this trend is the fact that cash as a percentage of assets, which peaked at more than 9% in fiscal 2015, has since declined and will continue to do so through fiscal 2018," says Mihoko Manabe, a Moody's Associate Managing Director. "Looking ahead, we also expect that the rated companies' cash holdings, which totaled JPY33.7 trillion (USD306 billion) at the end of fiscal 2017, will rise 2% in fiscal 2018 and hold steady in fiscal 2019, a slowdown from growth of 5% in fiscal 2017," says Manabe.

  • GlobeNewswire8 days ago

    Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR.

  • GlobeNewswire11 days ago

    Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR.

  • GlobeNewswire12 days ago

    Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR.

  • GlobeNewswire13 days ago

    Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR.

  • GlobeNewswire13 days ago

    Director/PDMR Shareholding

    October 2, 2018– Shire plc. Notification of transactions by person discharging managerial responsibilities. Sarah Rixon Senior Company Secretarial Assistant.

  • GlobeNewswire14 days ago

    Shire plc: Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR.

  • GlobeNewswire15 days ago

    Form 8 (DD) - Ian Clark

    FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2.

  • GlobeNewswire15 days ago

    Form 8 (DD) - Olivier Bohuon

    FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2.

  • GlobeNewswire15 days ago

    Form 8 (DD) - David Ginsburg

    FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2.

  • GlobeNewswire15 days ago

    Form 8 (DD) - Gail Fosler

    FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2.

  • GlobeNewswire15 days ago

    Form 8 (DD) - Sara Mathew

    FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2.

  • GlobeNewswire15 days ago

    Form 8 (DD) - Steven Gillis

    FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2.

  • GlobeNewswire15 days ago

    Form 8 (DD) - Albert Stroucken

    FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2.

  • GlobeNewswire15 days ago

    Form 8 (DD) - Susan Kilsby

    FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2.

  • GlobeNewswire15 days ago

    Shire plc: Rule 2.9 Announcement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.. ...

  • Takeda's $62 billion Shire bid faces November 6 EU antitrust deadline
    Reuters17 days ago

    Takeda's $62 billion Shire bid faces November 6 EU antitrust deadline

    EU antitrust regulators will decide by Nov. 6 whether to allow Japanese drugmaker Takeda Pharmaceutical's $62-billion takeover of London-listed Shire Plc , the European Commission said on Friday. The EU ...

  • Reuters17 days ago

    Takeda's $62 billion Shire bid faces Nov. 6 EU antitrust deadline

    BRUSSELS (Reuters) - EU antitrust regulators will decide by Nov. 6 whether to allow Japanese drugmaker Takeda Pharmaceutical's $62-billion (47.5 billion pounds) takeover of London-listed Shire Plc (SHP.L), ...